Back
iShares S&P Small-Cap 600 Growth ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
38
IJT
iShares S&P Small-Cap 600 Growth ETF
Last Price:
$123.85
Seasonality Move:
4.01%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$99.75
Seasonality Move:
6.73%
Sell
38
iShares S&P Small-Cap 600 Growth ETF (IJT)
is a Sell
Is iShares S&P Small-Cap 600 Growth ETF a Buy, Sell or Hold?
-
The current iShares S&P Small-Cap 600 Growth ETF [IJT] share price is $126.98. The Score for IJT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
IJT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $103.03. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IJT Stock Price Chart
What is iShares S&P Small-Cap 600 Growth ETF's stock price today?
-
The iShares S&P Small-Cap 600 Growth ETF share price today is $126.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IJT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $103.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
IJT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.24 | Sell |
Relative Strength Index (14 RSI): | 28.49 | Sell |
Chaikin Money Flow: | 141711 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (131.01 - 141.27) | Sell |
Bollinger Bands (100): | (134.55 - 145.17) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.04 | Sell |
Relative Strength Index (14 RSI): | 40.42 | Sell |
Chaikin Money Flow: | -321546 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.54 - 113.06) | Sell |
Bollinger Bands (100): | (110.42 - 127.2) | Sell |
IJT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.56 | Sell |
20-day SMA: | 134.94 | Sell |
50-day SMA: | 137 | Sell |
200-day SMA: | 136.57 | Sell |
8-day EMA: | 129.59 | Sell |
20-day EMA: | 133.31 | Sell |
50-day EMA: | 136.7 | Sell |
200-day EMA: | 135.53 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.67 | Sell |
20-day SMA: | 107.25 | Sell |
50-day SMA: | 114.66 | Sell |
200-day SMA: | 126.84 | Sell |
8-day EMA: | 105.01 | Sell |
20-day EMA: | 107.54 | Sell |
50-day EMA: | 112.76 | Sell |
200-day EMA: | 121.2 | Sell |
iShares S&P Small-Cap 600 Growth ETF Earnings Growth & IJT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.42 per share, an increase next quarter of $0.15 per share, an increase this year of $6.18 per share, and an increase next year of $5.61 per share.
iShares S&P Small-Cap 600 Growth ETF Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |